ELMD vs SPXC

For growth investors, Electromed, Inc.

(ELMD) is the stronger pick with 17. 0% revenue growth year-over-year, versus 14. 2% for SPX Technologies, Inc. (SPXC). Electromed, Inc. (ELMD) offers the better valuation at 31. 2x trailing P/E (24. 4x forward), making it the more compelling value choice. Analysts rate Electromed, Inc. (ELMD) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Electromed, Inc.

(ELMD) is the cheapest at 31. 2x versus SPX Technologies, Inc. at 40. 5x. On forward P/E, Electromed, Inc. is actually cheaper at 24. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: SPX Technologies, Inc. wins at 1. 37x versus Electromed, Inc. 's 1. 90x — a reasonable growth-adjusted valuation.

Over the past 5 years, SPX Technologies, Inc.

(SPXC) delivered a total return of +222. 6%, compared to +178. 1% for Electromed, Inc. (ELMD). Over 10 years, the gap is even starker: SPXC returned +1183% versus ELMD's +482. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Electromed, Inc.

(ELMD) is the lower-risk stock at 1. 03β versus SPX Technologies, Inc. 's 1. 30β — meaning SPXC is approximately 27% more volatile than ELMD relative to the S&P 500. On balance sheet safety, Electromed, Inc. (ELMD) carries a lower debt/equity ratio of 0% versus 22% for SPX Technologies, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Electromed, Inc.

(ELMD) is pulling ahead at 17. 0% versus 14. 2% for SPX Technologies, Inc. (SPXC). On earnings-per-share growth, the picture is similar: Electromed, Inc. grew EPS 48. 3% year-over-year, compared to 17. 9% for SPX Technologies, Inc.. Over a 3-year CAGR, SPXC leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Electromed, Inc.

(ELMD) is the more profitable company, earning 11. 8% net margin versus 10. 8% for SPX Technologies, Inc. — meaning it keeps 11. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SPXC leads at 16. 8% versus 15. 1% for ELMD. At the gross margin level — before operating expenses — ELMD leads at 78. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, SPX Technologies, Inc. (SPXC) is the more undervalued stock at a PEG of 1. 37x versus Electromed, Inc. 's 1. 90x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Electromed, Inc. (ELMD) trades at 24. 4x forward P/E versus 26. 1x for SPX Technologies, Inc. — 1. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ELMD: 41. 5% to $38. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, SPX Technologies, Inc.

(SPXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1183% 10Y return). Both have compounded well over 10 years (SPXC: +1183%, ELMD: +482. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ELMD (Healthcare) and SPXC (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ELMD is a small-cap high-growth stock; SPXC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.